Menstrual fluid collected from tampons could one day provide a simple, noninvasive way to measure a biomarker of nerve damage and potentially track disease activity in neurological conditions such as multiple sclerosis (MS). Researchers at Nextgen Jane, in collaboration with Siemens Healthineers…
Discussion
Between my tours with the Army, a new course was added to the curriculum for me to teach — a two-week basic combat skills course for support personnel. The logic was that if a mechanic or cook attached to a special forces team overseas ever had to do something outside…
Discussion
The first participant has been dosed in an investigator-initiated Phase 2 clinical trial testing Neuraly‘s experimental medication pegsebrenatide as a potential treatment for progressive forms of multiple sclerosis (MS). Called TAG-MS (NCT07497399), the study is being led by Ellen Mowry, MD, at…
Discussion
Every year, warmer weather arrives with a collective exhale as people spend more time outdoors, enjoying sunlight that stretches into the evening and patio dinners. But for me, living with multiple sclerosis (MS), the arrival of summer lands more like a quiet tightening in my chest. I find myself…
Discussion
A pilot clinical trial in the U.S. is enrolling people with relapsing-remitting multiple sclerosis (RRMS) to test Setpoint Medical’s implantable nerve stimulation device, which is designed to reduce inflammation and promote myelin repair. The trial (NCT06796504) is enrolling up to 60 people, ages 22-50, and will evaluate…
Get regular updates to your inbox.
